FDA

Updated ET, Sat ,

Biogen's drug has aroused concerns, with some experts saying it isn't proven to slow the disease. ...
The drug, which will be marketed as Aduhelm, is the first ever that US regulators say can treat the underlying disease and its memory-robbing effects, rather than just symptoms like anxiety and ins… ...
Former FDA Commissioner Dr. Peggy Hamburg and NBC's Dr. John Torres join Andrea Mitchell with their analysis of the FDA's approving a new Alzheimer's drug for the first time since 2003, and why that approval comes with controversy. ...
The Food and Drug Administration (FDA) on Monday approved what it described as a "first-of-its-kind" treatment for Alzheimer's disease. ...

( )